Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leflunomide for Treatment of COVID-19
2020-002952-18Phase 2Unknown
- Sponsor
- Ashford and St Peter's Hospitals NHS Foundation Trust
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of leflunomide in coronavirus disease 2019 (COVID-19), sponsored by Ashford and St Peter's Hospitals NHS Foundation Trust. Primary endpoint: Time to Clinical Improvement (TTCI). Status: unknown.
02
Drugs
leflunomide
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-002952-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-002952-18.